NASH Updates: Boston Pharma, Viking Line Up As Serious Competitors

New Data Coming Out Of AASLD

 
• By Joseph Haas
  
2023 AASLD
Boston Pharma, Viking and Akero raised their profiles in NASH at AASLD 2024 • Source: Scrip

More from Conferences

More from Therapy Areas